To bring access to tomorrow’s breakthrough therapies, novel devices, and new approaches to today’s patients, academic medical centers must embrace and promote clinical research as the path to knowledge that will serve patients locally and, ultimately, globally.
Launched with help from Cedars-Sinai, the National Institutes of Health’s All of Us Research Program, is gathering genetic, biological, environmental, health, and lifestyle data from a million volunteers over 10 years. The program will use this valuable data for thousands of studies into a wide variety of health conditions in order to develop more effective ways to prevent and treat disease.
Sarah Kilpatrick, MD, PhD, discusses the goal of gender equity in health research to prevent women from being misdiagnosed, overprescribed, or otherwise harmed by a medical system that has been designed predominantly around the male body.
Can precision medicine help solve the problem of inadequate diversity in medical research? The practice of precision medicine may contain its own solution: Technology has made it easier than ever to tap into the complexity of all humankind.
Mysteries surrounding cancer genomics have been stripped away in recent years, exposing the disease as a target for precision medicine. Monica Mita, MD, co-director of Experimental Therapeutics at Cedars-Sinai, explains how oncology research stands to gain ground in the near future.
No single person, institution, or nation is as smart as all of us thinking together. That is the driving principle behind an ambitious research collaboration that could lead to more effective cancer treatments. Cedars-Sinai has combined forces with the Translational Read On